Caricamento...
Mechanisms and Management of Chimeric Antigen Receptor T-Cell Therapy Related Toxicities
Chimeric antigen receptor T-cell (CAR-T) therapy has proven to be a very effective cancer immunotherapy. Axicabtagene ciloleucel and Tisagenlecleucel are the first in class anti-CD19 CAR-T-cells currently available for relapsed-refractory adult large B-cell lymphoma. Tisagenlecleucel is also availab...
Salvato in:
| Pubblicato in: | BioDrugs |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2019
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6733400/ https://ncbi.nlm.nih.gov/pubmed/30560413 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40259-018-0324-z |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|